BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beloor J, Zeller S, Choi CS, Lee SK, Kumar P. Cationic cell-penetrating peptides as vehicles for siRNA delivery. Ther Deliv 2015;6:491-507. [PMID: 25996046 DOI: 10.4155/tde.15.2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ye J, Liu E, Gong J, Wang J, Huang Y, He H, Yang VC. High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA. Theranostics 2017;7:2495-508. [PMID: 28744330 DOI: 10.7150/thno.19863] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
2 Weidle UH, Birzele F, Nopora A. Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models. Cancer Genomics Proteomics 2019;16:451-64. [PMID: 31659100 DOI: 10.21873/cgp.20149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rabbani PS, Zhou A, Borab ZM, Frezzo JA, Srivastava N, More HT, Rifkin WJ, David JA, Berens SJ, Chen R, Hameedi S, Junejo MH, Kim C, Sartor RA, Liu CF, Saadeh PB, Montclare JK, Ceradini DJ. Novel lipoproteoplex delivers Keap1 siRNA based gene therapy to accelerate diabetic wound healing. Biomaterials 2017;132:1-15. [PMID: 28391065 DOI: 10.1016/j.biomaterials.2017.04.001] [Cited by in F6Publishing: 54] [Reference Citation Analysis]
4 Sadeghian I, Heidari R, Sadeghian S, Raee MJ, Negahdaripour M. Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines. Eur J Pharm Sci 2021;169:106094. [PMID: 34896590 DOI: 10.1016/j.ejps.2021.106094] [Reference Citation Analysis]
5 Liao W, Li W, Zhang T, Kirberger M, Liu J, Wang P, Chen W, Wang Y. Powering up the molecular therapy of RNA interference by novel nanoparticles. Biomater Sci 2016;4:1051-61. [DOI: 10.1039/c6bm00204h] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
6 Xie J, Bi Y, Zhang H, Dong S, Teng L, Lee RJ, Yang Z. Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application. Front Pharmacol 2020;11:697. [PMID: 32508641 DOI: 10.3389/fphar.2020.00697] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 21.5] [Reference Citation Analysis]
7 Yu X, Xue L, Zhao J, Zhao S, Wu D, Liu HY. Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery. Pharmaceutics 2021;13:2182. [PMID: 34959463 DOI: 10.3390/pharmaceutics13122182] [Reference Citation Analysis]
8 Zhao J, Lin H, Wang L, Guo K, Jing R, Li X, Chen Y, Hu Z, Gao S, Xu N. Suppression of FGF5 and FGF18 Expression by Cholesterol-Modified siRNAs Promotes Hair Growth in Mice. Front Pharmacol 2021;12:666860. [PMID: 34305588 DOI: 10.3389/fphar.2021.666860] [Reference Citation Analysis]
9 Ullah I, Chung K, Beloor J, Kim J, Cho M, Kim N, Lee KY, Kumar P, Lee SK. Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA. J Drug Target 2017;25:320-9. [PMID: 27820977 DOI: 10.1080/1061186X.2016.1258566] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Khan MM, Filipczak N, Torchilin VP. Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer. J Control Release 2021;330:1220-8. [PMID: 33248708 DOI: 10.1016/j.jconrel.2020.11.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
11 Alexander-Bryant AA, Zhang H, Attaway CC, Pugh W, Eggart L, Sansevere RM, Andino LM, Dinh L, Cantini LP, Jakymiw A. Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo. Oral Oncol 2017;72:123-31. [PMID: 28797448 DOI: 10.1016/j.oraloncology.2017.07.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
12 Ruseska I, Zimmer A. Internalization mechanisms of cell-penetrating peptides. Beilstein J Nanotechnol 2020;11:101-23. [PMID: 31976201 DOI: 10.3762/bjnano.11.10] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 31.0] [Reference Citation Analysis]
13 Chen S, Li J, Ma X, Liu F, Yan G. Cationic Peptide-Modified Gold Nanostars as Efficient Delivery Platform for RNA Interference Antitumor Therapy. Polymers (Basel) 2021;13:3764. [PMID: 34771323 DOI: 10.3390/polym13213764] [Reference Citation Analysis]
14 Christensen MV, Kongstad KT, Sondergaard TE, Staerk D, Nielsen HM, Franzyk H, Wimmer R. 19F-substituted amino acids as an alternative to fluorophore labels: monitoring of degradation and cellular uptake of analogues of penetratin by 19F NMR. J Biomol NMR 2019;73:167-82. [PMID: 30887171 DOI: 10.1007/s10858-019-00239-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
15 Yazdi MK, Zarrintaj P, Ghavami M, Alizadeh R, Saeb MR. Protein and peptide-based delivery systems. Nanoengineered Biomaterials for Advanced Drug Delivery. Elsevier; 2020. pp. 145-61. [DOI: 10.1016/b978-0-08-102985-5.00007-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Saw PE, Song EW. siRNA therapeutics: a clinical reality. Sci China Life Sci 2020;63:485-500. [PMID: 31054052 DOI: 10.1007/s11427-018-9438-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 17.0] [Reference Citation Analysis]
17 Tuttolomondo M, Ditzel HJ. Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides. Methods Mol Biol 2021;2282:353-76. [PMID: 33928584 DOI: 10.1007/978-1-0716-1298-9_19] [Reference Citation Analysis]